- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT06424327
Een register voor mensen met longkanker
Pulmonale segmentectomie voor longkanker: een real-world internationaal register-TSOG 108
Participants will complete questionnaires before surgery, between 2 to 4 weeks after surgery, and 6 months after surgery.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Contacten en locaties
Studiecontact
- Naam: David Jones, MD
- Telefoonnummer: 212-639-6428
- E-mail: jonesd2@mskcc.org
Studie Contact Back-up
- Naam: Bernard Park, MD
- Telefoonnummer: 646-888-3346
- E-mail: parkb@mskcc.org
Studie Locaties
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 2C4
- Werving
- University Health Network (Data Collection Only)
-
Contact:
- Elliot Wakeam, MD
- E-mail: elliot.wakeam@uhn.ca
-
-
Quebec
-
Montreal, Quebec, Canada, H2L 4M1
- Werving
- Centre Hospitalier de l'Université de Montreal (Data Collection Only)
-
Contact:
- Moishe Liberman, MD. PhD
- Telefoonnummer: 514-890-8000, ext: 26832
-
-
-
-
Arizona
-
Tucson, Arizona, Verenigde Staten, 85704
- Werving
- University of Arizona (Data Collection Only)
-
Contact:
- Praveen Sridhar, MD
- Telefoonnummer: 520-694-2873
- E-mail: psridhar@arizona.edu
-
-
California
-
San Diego, California, Verenigde Staten, 92103
- Werving
- University of California San Diego (Data collection)
-
Contact:
- Joshua Boys, MD
- Telefoonnummer: 858-657-7777
-
-
Illinois
-
Chicago, Illinois, Verenigde Staten, 606012
- Werving
- Rush University Medical Center (Data collection only)
-
Contact:
- Christopher Seder, MD
- Telefoonnummer: 312-738-3732
-
Evanston, Illinois, Verenigde Staten, 60201
- Werving
- Endeavor Health
-
Contact:
- Seth Krantz, MD
- Telefoonnummer: 847-570-2868
-
-
Massachusetts
-
Boston, Massachusetts, Verenigde Staten, 02114
- Werving
- Massachusetts General Hospital Cancer Center (Data Collection Only)
-
Contact:
- Michael Lanuti, MD
- Telefoonnummer: 617-726-6751
-
Boston, Massachusetts, Verenigde Staten, 02115
- Werving
- Brigham and Women's Hospital (Data Collection Only)
-
Contact:
- Paula A Ugalde Figueroa, MD
- Telefoonnummer: 617-525-7532
-
-
Michigan
-
Ann Arbor, Michigan, Verenigde Staten, 48109
- Werving
- University of Michigan (Data Collection Only)
-
Contact:
- Jules Lin, MD
- Telefoonnummer: 734-936-8857
-
-
New Jersey
-
Basking Ridge, New Jersey, Verenigde Staten, 07920
- Werving
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
-
Contact:
- David Jones, MD
- Telefoonnummer: 212-639-6428
-
Middletown, New Jersey, Verenigde Staten, 07748
- Werving
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities)
-
Contact:
- David Jones, MD
- Telefoonnummer: 212-639-6428
-
Montvale, New Jersey, Verenigde Staten, 07645
- Werving
- Memorial Sloan Kettering Bergen (Limited Protocol Activities)
-
Contact:
- David Jones, MD
- Telefoonnummer: 212-639-6428
-
-
New York
-
Commack, New York, Verenigde Staten, 11725
- Werving
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)
-
Contact:
- David Jones, MD
- Telefoonnummer: 212-639-6428
-
Harrison, New York, Verenigde Staten, 10604
- Werving
- Memorial Sloan Kettering Westchester (Limited Protocol Activities)
-
Contact:
- David Jones, MD
- Telefoonnummer: 212-639-6428
-
New York, New York, Verenigde Staten, 10065
- Werving
- Memorial Sloan Kettering Cancer Center (All Protocol Activities)
-
Contact:
- Yuan Liu, MD, PhD
- Telefoonnummer: 646-888-3640
-
Contact:
- David Jones, MD
- Telefoonnummer: 212-639-6428
-
Hoofdonderzoeker:
- David Jones, PhD
-
Uniondale, New York, Verenigde Staten, 11553
- Werving
- Memorial Sloan Kettering Nassau (Limited Protocol Activities)
-
Contact:
- David Jones, MD
- Telefoonnummer: 212-639-6428
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Verenigde Staten, 19107
- Werving
- Thomas Jefferson University Hospital (Data Collection Only)
-
Contact:
- Nathaniel Evans III, MD
- E-mail: nathaniel.evans@jefferson.edu
-
Pittsburgh, Pennsylvania, Verenigde Staten, 15212
- Werving
- ALLEGHENY HEALTH NETWORK (Data Collection Only)
-
Contact:
- Benny Weksler, MD
- Telefoonnummer: 412-359-6137
-
-
Texas
-
Dallas, Texas, Verenigde Staten, 75246
- Werving
- Baylor University Medical Center (Data Collection Only)
-
Contact:
- Shanda Blackmon, MD, MPH
- Telefoonnummer: 713-198-6376
- E-mail: sshanda.blackmon@bcm.edu
-
Houston, Texas, Verenigde Staten, 77030
- Werving
- MD Anderson Cancer Center (Data Collection Only)
-
Contact:
- David Rice, MD
- Telefoonnummer: 800-392-1611
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
All study subjects will be recruited from their respective clinics (i.e., Thoracic Surgery, Pulmonary, Survivorship, etc.) at participating sites. Potential research subjects will be identified by a member of the patient's treatment team, the protocol investigator, or research team by screening patients' medical records. If eligible, the study will be discussed with each patient.
Beschrijving
Inclusion Criteria:
- Age ≥18 years
- Patients suitable for segmentectomy, according to the treating surgeon
- Clinical Stage I with suspected NSCLC, classified preoperatively based on the AJCC TNM staging manual, 9th edition o Note: Tissue diagnosis of NSCLC is not required before enrollment. A pathologic diagnosis of NSCLC may be confirmed preoperatively with biopsy, intraoperatively with frozen section, or postoperatively on final pathology
Exclusion Criteria:
-
Actively receiving lung cancer treatment or a history of lung cancer in the previous 5 years
-
History of chemotherapy or radiation therapy for a previous lung cancer
-
Synchronous secondary cancer in the lung or elsewhere in the body at the time of surgery
-
Carcinoid tumors
-
History of other malignancies within the past 3 years, with the exception of non-melanoma skin cancer, superficial bladder cancer, and carcinoma in situ of the cervix
-
Actively receiving treatment for other malignancies
-
Cases of lobectomy in conjunction with segmentectomy from another lobe and ≥2 segmentectomies from different lobes either en bloc or separate will be excluded from the primary analysis.
- Multi-segmental resection from the same lobe is not a criterion for exclusion.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Observatiemodellen: COHORT
- Tijdsperspectieven: PROSPECTIVE
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
|---|---|
|
Participants with Lung Cancer
Participants undergoing planned pulmonary segmentectomy for primary lung cancer |
Participants-reported outcomes will be collected using the Patient-Reported Outcomes Measurement Information System (PROMIS). PROMIS is a web-based platform developed by the National Institutes of Health. Scoring is standardized on a scale from 0 to 100, with a population mean of 50 and standard deviation of 10 units. High scores mean more of the concept being measured. This study will use PROMIS surveys assessing three domains: physical function (PROMIS bank version 2.0), pain interference (PROMIS bank version 1.1), and dyspnea severity (PROMIS bank version 1.0)
Andere namen:
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Determine 3-year disease-free survival/DFS among patients undergoing pulmonary segmentectomy for lung cancer.
Tijdsspanne: 3 years
|
DFS is measured from the date of surgery to the date of recurrence or death |
3 years
|
|
Determine 5-year disease-free survival/DFS among patients undergoing pulmonary segmentectomy for lung cancer.
Tijdsspanne: 5 years
|
DFS is measured from the date of surgery to the date of recurrence or death |
5 years
|
Medewerkers en onderzoekers
Onderzoekers
- Hoofdonderzoeker: David Jones, MD, Memorial Sloan Kettering Cancer Center
Publicaties en nuttige links
Nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 24-127
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .